The pharmacology of peptic ulcer disease.
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D005750:Gastric Juice / Q000378:metabolism; D005755:Gastrins / Q000097:blood; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000191:economics; D012008:Recurrence
D000863:Antacids; D000897:Anti-Ulcer Agents; D005755:Gastrins; D010276:Parasympatholytics; D002927:Cimetidine; D002229:Carbenoxolone; D001729:Bismuth